Posted:
9/19/2025, 5:31:16 AM
Location(s):
California, United States ⋅ Acton, Massachusetts, United States ⋅ Massachusetts, United States ⋅ San Diego, California, United States
Experience Level(s):
Expert or higher
Field(s):
Product
Workplace Type:
Hybrid
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable and waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero finger sticks, and is fully controlled by a compatible personal smartphone.
Insulet recently received FDA clearance for its Omnipod 5 for Type 2 Diabetes in the US, making it the first and only Automated Insulin Delivery (AID) system indicated for both Type 1 and Type 2 Diabetes. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Studies have demonstrated the clinical and lifestyle advantages of insulin pump therapy over multiple daily insulin injections (MDI). However, many people still choose MDI therapy largely due to the complexity, cost, and inconvenience of conventional pump technology. The Omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with insulin- requiring diabetes.
Insulet was founded in 2000 with the mission to improve the lives of people with diabetes and enable customers to enjoy simplicity, freedom, and healthier lives through innovative technology. The Company’s world headquarters and state-of-the-art automated manufacturing facility are located in Acton, Massachusetts with global offices in the U.K., France, Germany, Netherlands, Canada, Mexico, Australia, and the United Arab Emirates. Omnipod products are available in 25 countries around the world.
Insulet recently concluded its ninth consecutive year of 20% or more revenue growth, and more than doubled its intellectual property portfolio over the last year. Insulet is proud to be recognized as a 2024 LinkedIn Top Company in the United States; recognized as a Great Place to Work® in eight international locations in 2023; and ranked as one of America’s most responsible companies by Newsweek for 2025.
For more information, visit: insulet.com and omnipod.com
The Head of the Program Management Office (PMO) establishes and leads an enterprise PMO that serves growth, technology, and innovation initiatives across the company. This leader evolves our agile delivery model for technology projects and standardizes end-to-end program governance from concept through launch, ensuring disciplined planning, tracking, and execution across hardware, software/cloud/data, regulatory, quality, manufacturing, supply chain, and commercial readiness. The PMO leader is a key partner to the leadership team, partnering with SVP, R&D and SVP, CTO to establish and execute platform approaches to innovation execution. The PMO will also drive measurement and standards of performance for engineering execution, quality, capacity management, and benefits realization aligned to strategic growth objectives.
Location: Greater Boston, MA, or San Diego with frequent presence required at Insulet’s Acton headquarters.
Additional Information:
The US base salary range for this full-time position is $0.00 - $0.00. Our salary ranges are determined by role, level, and location. The range displayed on each job posting reflects the minimum and maximum target for new hire salaries for the position in the primary work location in the US. Within the range, individual pay is determined by work location and additional factors, including job-related skills, experience, and relevant education or training. Your Talent Acquisition Specialist can share more about the specific salary range for your preferred location during the hiring process. Please note that the compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits.Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
Website: https://insulet.com/
Headquarter Location: Bedford, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2000
IPO Status: Private
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Diabetes ⋅ Health Care ⋅ Medical Device